10.1002/ijc.22921 Int
Tirzepatide is not recommended for individuals with medullary thyroid carcinoma, MEN2, and certain health conditions such as pancreatitis and gallstones
Medication adjustment that was implemented in our study included dose reduction or discontinuation of VPA (6/11), reduction of PHT (2/11) and dose increase in other ASMs (LEV, LCS, OXC) (3/11)
I try to encourage every single one of my patients to seek out a body composition scale to at least get on it just once before they start a GLP-1, just so they already know their baseline lean body mass status, she says
Precision Plus Protein Dual Color Standards were purchased from BioRad
According to FDA prescribing information, gastrointestinal side effects are typically most pronounced during dose initiation and escalation, and they often diminish over time as the body adapts to the medication